Your browser doesn't support javascript.
loading
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.
Tang, Shi-Chuan; Zhang, Kai-Ling; Lin, Kong-Ying; Tang, Yi-Dan; Fu, Jun; Zhou, Wei-Ping; Zhang, Jian-Xi; Kong, Jie; He, Xiao-Lu; Sun, Zheng-Hong; Luo, Cong; Liu, Hong-Zhi; Lai, Yong-Ping; Zeng, Yong-Yi.
Afiliação
  • Tang SC; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, No. 312, Xihong Road, Fuzhou, 350025, Fujian Province, China.
  • Zhang KL; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Lin KY; Department of Gastroenterology, Wenjiang District People's Hospital of Chengdu, Chengdu, China.
  • Tang YD; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, No. 312, Xihong Road, Fuzhou, 350025, Fujian Province, China.
  • Fu J; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Zhou WP; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Zhang JX; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, No. 312, Xihong Road, Fuzhou, 350025, Fujian Province, China.
  • Kong J; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • He XL; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, China.
  • Sun ZH; Department of Hepatobiliary Surgery, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China.
  • Luo C; Department of Hepatobiliary, Heze Municipal Hospital, Shandong, China.
  • Liu HZ; Department of Hepatobiliary Surgery, Chengdu Second People's Hospital, Chengdu, China.
  • Lai YP; Department of General Surgery, Guizhou Maotai Hospital, Zunyi, China.
  • Zeng YY; Department of Hepatopancreatobiliary Surgery, Zizhong County People's Hospital, Zizhong, China.
Hepatol Int ; 18(2): 623-635, 2024 Apr.
Article em En | MEDLINE | ID: mdl-37880566
ABSTRACT

BACKGROUND:

The impact of hepatic resection type on long-term oncological prognosis of patients with early-stage hepatocellular carcinoma (HCC) has not been systematically investigated. We sought to determine risk factors, recurrence patterns, and survival outcomes after anatomical resection (AR) versus non-anatomical resection (NAR) for early-stage HCC.

METHODS:

From a prospectively collected multicenter database, consecutive patients undergoing curative hepatectomy for early-stage HCC were identified. Recurrence patterns, overall survival (OS), recurrence-free survival (RFS), and risk factors were investigated in patients undergoing AR versus NAR using propensity score matching (PSM), subgroup analysis, and COX regression analysis.

RESULTS:

A total of 3585 patients with early-stage HCC were enrolled, including 1287 and 2298 in the AR and NAR groups, respectively. After PSM, the OS and RFS of patients in the AR group were 58.8% and 42.7%, which were higher than those in the NAR group (52.2% and 30.6%, both p < 0.01). The benefits of AR were consistent across most subgroup analyses of OS and RFS. Multivariable COX regression analysis showed that AR was independently associated with better OS and RFS. Notably, although recurrence patterns were comparable, the risk factors for recurrence were not identical for AR versus NAR. Microvascular invasion and narrow resection margin were only associated with a higher recurrence rate after NAR.

CONCLUSIONS:

This study demonstrated that AR decreases the risk of tumor recurrence and improves OS and RFS in patients with early-stage HCC. AR should be adopted as long as such a surgical maneuver is feasible for initial treatment of early-stage HCC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Hepatol Int Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Hepatol Int Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China